Physical Therapists in Long Valley, NJ Accepting Medicare
5 Physical Therapists found. Showing 1 - 5
 Kira Aileen Ellis, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1 E Gate Rd, Long Valley, NJ 07853 Phone: 201-317-2901 |
 Louis K. Luckhardt, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9 Fairview Ave, Long Valley, NJ 07853 Phone: 908-876-4892 |
Dr. Nicholas Mckaba, PT, DPT Physical Therapist - Sports Medicare: Not Enrolled in Medicare Practice Location: 33 Ascot Dr, Long Valley, NJ 07853 Phone: 908-458-1230 |
Lydia Sandra Millner, D.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 358 Drakestown Rd, Long Valley, NJ 07853 Phone: 908-813-2352 |
Janel Grace Hooper, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 33 Mountain View Avenue, Long Valley, NJ 07853 Phone: 973-670-6693 |
News Archive
Radiation therapy critical to treating brain tumors, but linked to significant adverse effects
Radiation therapy using high-energy particles, like x-rays or electron beams, is a common and critical component in successfully treating patients with brain tumors, but it is also associated with significant adverse effects, such as neuronal loss in adjacent healthy tissues.
Large-scale genetic study of E. coli illustrates complexity of drug resistant 'superbugs'
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains.
Community-driven approaches needed for reducing cancer-death disparities
Cancer death rates for African-Americans far exceed non-Hispanic Caucasians in the United States, and only community-driven approaches to reducing health disparities will lessen the gap, says Edward Partridge, M.D., president-elect of the American Cancer Society (ACS) National Board of Directors and director of the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center.
Chronic disease expert: U.S. health care system needs to treat 'whole person'
Kaiser Health News staff writer Jessica Marcy interviews Kate Lorig, director of the Patient Education Research Center at Stanford University, about the toll of chronic diseases.
Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
› Verified 3 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Occupational Therapists
Optometrists